Growing evidence from tissue culture studies, laboratory controlled animal studies, and human clinical trials suggests that flavonoid-rich Cranberry and Blueberry have potential ability to limit the development and severity of certain cancers, and also vascular diseases including atherosclerosis (hardening of the arteries), ischemic stroke (the most common form of stroke commonly known as a blockage stroke), and also the neurodegenerative diseases of aging (examples could be Alzheimer’s disease and Parkinson’s disease).The fruits contain a variety of polyphenols that could contribute to these protective effects including Anthocyanins, Flavonols, Proanthocyanidins, Stilbenes, Cinnamic Acids, and Triterpenoids. Cranberry and Blueberry Polyphenols are likely to act in a variety of mechanisms; counteracting free radicals and the oxidative stress they generate, decrease inflammation, control interactions at macromolecular levels or at the level of the cell, and influence gene activity that affect the disease processes. The evidence is pointing to a potential role for Cranberry and Blueberry in the prevention of cancer and vascular diseases justifying further research including bioavailability and metabolism of their constituents.
Study confirms that Flaxseed inhibits the growth of prostate cancer Researchers at Duke University Medical Center split men into 4 groups. One group was supplemented with 30 grams of ground flaxseed each day, the second group was also but they were additionally placed on a low fat diet. The third group was placed on a low fat diet only without flaxseed, and the last group served as the control group without a special diet and no flaxseed.